Yuwei Hua

机构：Lianyungang Runzhong Pharmaceutical (China)

发表论文 4 篇 · 总被引 52 次 · h-index 3

代表论文

• Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study (2021 · Cancer Immunology Immunotherapy · 被引 30)
• Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study (2024 · Frontiers in Immunology · 被引 13)
• Predictive model of chemotherapy-related toxicity in elderly Chinese cancer patients (2023 · Frontiers in Pharmacology · 被引 9)
• Low-glutelin rice as a food-based strategy for protein restriction: Genetic development, structural engineering, and nutritional consequences (2025 · Trends in Food Science & Technology)